Liminal BioSciences Reports Third Quarter Financial Results

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/24/2026

1. RNG
2. DECK
3. WDC
4. BYD
5. SPOT
6. WCN
7. BMY
8. TSCO
9. BE
10. SPY

Go back to Liminal BioSciences Reports Third Quarter Financial Results

Liminal BioSciences (LMNL) Reports Q3 Revenues of $600K

November 12, 2020 5:14 PM EST

Liminal BioSciences (NASDAQ: LMNL) reported Q3 revenue for the quarter came in at $600 thousand, versus $800 thousand reported last year.

Third Quarter Financial Results:

Following the sale of our bioseparations business segment in the fourth quarter of 2019, we have restated the prior periods to remove the impact of those operations from the lines in the financial statements and have reclassified those results to the discontinued operations line in the financial statements. All amounts presented in this section are in C$ unless otherwise specified.

Cash Position: Cash and cash equivalents at September 30, 2020 were... More